-
Featured
Low-risk Incidental Prostate Cancer in Men with Bladder Cancer May Be Associated with Longer Survival
Men with bladder cancer who have low-risk prostate cancer detected incidentally by radical cystoprostatectomy may actually have a more favorable prognosis than those who do not.
-
Featured
Ultrasound Therapy Yields Promising Results for Localized Prostate Cancer
At the American Urological Association's 2019 Annual Meeting, researchers presented the findings of a study on the effects transurethral ultrasound ablation (TULSA), a novel minimally invasive procedure that can reduce prostate size and prostate-specific antigens in patients with localized prostate cancer.
-
Featured
New Target Discovered for Prostate Cancer Immunotherapy
Genitourinary pathologists at Massachusetts General Hospital are the first to demonstrate that PD-L1 expression is highly prevalent in prostate tumor-associated nerves. Such nerves may represent an important target for immunotherapy regimens.
-
Predicted Survival After Radical Prostatectomy Varied by Race With a Trained Machine Classifier
Using a U.S. cancer database, Madhur Nayan, MDCM, PhD, and colleagues trained a machine-learning algorithm to predict survival after radical prostatectomy in race-specific subgroups. Nevertheless, the algorithm overestimated the survival of patients whose race was not listed as white or African American.
-
Combination Prostate Biopsy Can Overestimate Gleason Grade Compared with Surgical Pathology
By studying men who underwent both standard prostate biopsy and MRI–ultrasound targeted biopsy, Adam S. Feldman, MD, MPH, of the Department of Urology, and colleagues determined combination biopsy can overestimate Gleason grade compared to surgical pathology, presenting a risk of overtreatment.
-
Active Surveillance for Prostate Cancer
In this video, Keyan Salari, MD, PhD, discusses his team's work to identify the features of seemingly indolent prostate cancers that actually make them more aggressive.
Mass General Cancer Center Contributors
-
Adam Scott Feldman, MD, MPH
Director, Combined Harvard Urologic Oncology Fellowship, Director of Research and Urologic Oncologist, Department of Urology, Massachusetts General Hospital
Recent Article
Combination Prostate Biopsy Can Overestimate Gleason Grade Compared with Surgical Pathology -
Chin-Lee Wu, MD, PhD
Director, Genitourinary Pathology Service, Massachusetts General Hospital and Mass General Cancer Center, Professor of Pathology, Harvard Medical School
Recent Article
MRI–Ultrasound Fusion–Targeted Transperineal Prostate Biopsy Complements Standard Biopsy for Detecting Perineural Invasion -
Douglas Middleton Dahl, MD
Chief, Division of Urologic Oncology, Director of Robotic Surgery, Associate Professor, Harvard Medical School
Recent Article
MRI–Ultrasound Fusion–Targeted Transperineal Prostate Biopsy Complements Standard Biopsy for Detecting Perineural Invasion -